Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Endocannabinoid signaling influences neuroinflammation and neurodegeneration via cannabinoid receptors (CB1R and CB2R).
• CB1R function is modulated by membrane cholesterol, unlike CB2R.

Purpose of the Study:

• To investigate the structural basis for differential cholesterol interaction between CB1R and CB2R.
• To identify and modify a cholesterol recognition site in CB1R to mimic CB2R's interaction profile.

Main Methods:

• Identification of a cholesterol recognition/interaction amino acid sequence and consensus pattern in transmembrane helix 7 of human CB receptors.
• Site-directed mutagenesis of CB1R (Lys402 to Glycine) to alter its cholesterol interaction motif.
• Transient expression of wild-type and mutant receptors in human neuronal SH-SY5Y cells.
• Biochemical assays and immunofluorescence labeling to assess receptor localization and function.
• Fluorescence recovery after photobleaching (FRAP) analysis to evaluate membrane cholesterol sensitivity.

Main Results:

• A distinct cholesterol recognition/interaction motif was identified in the transmembrane helix 7 of CB1R and CB2R.
• Mutating Lys402 in CB1R created a motif similar to CB2R.
• The mutant CB1R showed reduced localization in cholesterol-rich microdomains.
• Mutant CB1R exhibited decreased sensitivity to increased membrane cholesterol levels.

Conclusions:

• A novel structural determinant in cannabinoid receptors, located in transmembrane helix 7, influences their interaction with cholesterol-rich membrane microdomains.
• This finding provides new insights into the regulation of CB1R and CB2R by membrane cholesterol.
• The identified motif may represent a therapeutic target for modulating endocannabinoid signaling in neurological diseases.